Jeil Pharmaceutical

Privately held: no public share price · South Korea

Assets

(1 total)
1Total Assets
0Approved
1Phase 3 / Filed
0Phase 1–2 / Early
1Diseases
Showing 1 of 1 assets
Target & Modality
Pioglitazone (JT-001)No recent activity
Phase 3
PPAR-gammaSmall molecule
Type 2 Diabetes

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

No financial reports recorded.